Pregabalin for treating paroxysmal painful symptoms in multiple sclerosis: a pilot study.
Solaro
Claudio
C
Boehmker
Margit
M
Tanganelli
Paolo
P
D000328:Adult; D000368:Aged; D000700:Analgesics / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D020528:Multiple Sclerosis, Chronic Progressive / Q000188:drug therapy*; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*; D009437:Neuralgia / Q000188:drug therapy*; D010865:Pilot Projects; D000069583:Pregabalin; D012720:Severity of Illness Index; D013997:Time Factors; D016896:Treatment Outcome; D005680:gamma-Aminobutyric Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000700:Analgesics; D000069583:Pregabalin; D005680:gamma-Aminobutyric Acid